FDA expands uses of Vyvanse to treat binge-eating disorder

The U.S. Food and Drug Administration has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults.

The U.S. Food and Drug Administration has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults.
SOURCE: Eating Disorders News From Medical News Today – Read entire story here.